Phase 2a study of BPN14770 in patients with Alzheimer's disease

Trial Profile

Phase 2a study of BPN14770 in patients with Alzheimer's disease

Planning
Phase of Trial: Phase II

Latest Information Update: 06 Nov 2017

At a glance

  • Drugs BPN 14770 (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2017 According to a Tetra Discovery Partners media release, the company anticipates to initiate this trial in the first half of 2018.
    • 05 Dec 2016 New trial record
    • 29 Nov 2016 According to a Tetra Discovery media release, this trial is expected to initiate during the second half 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top